BWS Financial Reaffirms “Buy” Rating for Hawkins (NASDAQ:HWKN)

Hawkins (NASDAQ:HWKN)‘s stock had its “buy” rating reaffirmed by BWS Financial in a research report issued to clients and investors on Thursday,Benzinga reports. They currently have a $200.00 price objective on the specialty chemicals company’s stock. BWS Financial’s target price points to a potential upside of 44.50% from the stock’s current price.

HWKN has been the topic of several other reports. Weiss Ratings downgraded shares of Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday, January 12th. Zacks Research upgraded Hawkins from a “strong sell” rating to a “hold” rating in a report on Friday, January 2nd. Two analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $162.50.

Hawkins Trading Down 10.0%

Shares of Hawkins stock traded down $15.34 on Thursday, reaching $138.41. The company had a trading volume of 452,212 shares, compared to its average volume of 132,140. The firm has a market cap of $2.89 billion, a price-to-earnings ratio of 34.86, a P/E/G ratio of 2.38 and a beta of 0.86. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.43 and a quick ratio of 1.49. The firm’s 50-day moving average price is $144.14 and its two-hundred day moving average price is $156.57. Hawkins has a 1 year low of $98.30 and a 1 year high of $186.15.

Hawkins (NASDAQ:HWKN) last issued its quarterly earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.03). Hawkins had a return on equity of 17.42% and a net margin of 7.95%.The company had revenue of $244.08 million during the quarter, compared to the consensus estimate of $252.51 million. As a group, research analysts predict that Hawkins will post 4 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Hawkins news, VP Drew M. Grahek purchased 1,587 shares of Hawkins stock in a transaction dated Monday, November 3rd. The stock was acquired at an average price of $126.34 per share, for a total transaction of $200,501.58. Following the acquisition, the vice president owned 39,640 shares in the company, valued at $5,008,117.60. This trade represents a 4.17% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 4.10% of the company’s stock.

Institutional Trading of Hawkins

Several hedge funds have recently modified their holdings of the company. Salomon & Ludwin LLC purchased a new position in Hawkins in the 3rd quarter worth $27,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new position in shares of Hawkins in the second quarter worth about $31,000. First Horizon Corp acquired a new stake in shares of Hawkins during the third quarter worth about $34,000. Sound Income Strategies LLC purchased a new stake in Hawkins in the fourth quarter valued at approximately $34,000. Finally, Aster Capital Management DIFC Ltd boosted its position in Hawkins by 62.2% in the third quarter. Aster Capital Management DIFC Ltd now owns 300 shares of the specialty chemicals company’s stock valued at $55,000 after buying an additional 115 shares during the last quarter. 69.71% of the stock is owned by hedge funds and other institutional investors.

Key Hawkins News

Here are the key news stories impacting Hawkins this week:

• Positive Sentiment: Board declared a quarterly cash dividend of $0.19 per share (payable Feb. 27; record date Feb. 13), maintaining shareholder returns — modest yield (~0.5%) but supportive of income-focused holders. Hawkins, Inc. Declares Quarterly Cash Dividend of $0.19 Per Share
• Positive Sentiment: Analyst commentary highlights a long runway for acquisitions that could compound growth over time — a potential strategic catalyst if management executes M&A effectively. This is a longer‑term positive that won’t offset an earnings miss immediately. Hawkins Inc.: Long Runway Of Potential Acquisitions It Could Compound Well
• Neutral Sentiment: Company press release and slide deck provide the full Q3 results and management commentary (useful for evaluating margin drivers, segment details, and any outlook comments). Investors should review slides for cost, volume, or pricing details that could affect near-term performance. Hawkins, Inc. Reports Third-Quarter Fiscal 2026 Results
• Neutral Sentiment: Local earnings coverage summarizes the results and provides additional color; useful for a quick recap but adds little new information beyond the press release. Hawkins: Fiscal Q3 Earnings Snapshot
• Negative Sentiment: Quarterly results missed estimates: EPS $0.72 vs. $0.75 consensus and revenue $244.08M vs. $252.51M consensus — the misses likely prompted the intra‑day selloff as they directly hit near-term earnings expectations. Margin and ROE remain reasonable (net margin ~7.95%, ROE ~17.4%) but miss on top-line and EPS is the immediate negative driver. Hawkins (HWKN) Q3 Earnings and Revenues Miss Estimates

About Hawkins

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.